Physician profile
Edwin L Houng
NPI 1124256748
$1,410.80
in general payments reported to CMS, 2019-2025
21 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $99.00 · 2021: $177 · 2022: $165 · 2023: $195 · 2024: $255 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $398.70 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $140.02 | 2019-2025 | Airsupra, Farxiga |
| Abbvie INC. | $116.44 | 2021-2025 | |
| Pfizer INC. | $112.73 | 2019-2024 | |
| Lilly USA, LLC | $112.03 | 2019-2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $66.36 | 2019-2020 | |
| Irhythm Technologies, INC. | $58.14 | 2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $55.93 | 2019-2020 | |
| Abbott Laboratories | $54.05 | 2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $51.62 | 2023-2024 | Rexulti |
| Glaxosmithkline, LLC. | $45.09 | 2022-2023 | Shingrix |
| Janssen Pharmaceuticals, INC | $33.25 | 2019-2021 | |
| Cranial Technologies, INC | $27.90 | 2019 | |
| Viiv Healthcare Company | $20.85 | 2025 | Apretude |
| Amgen INC. | $19.34 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.66 | 2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $18.02 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $17.51 | 2025 | Dexcom G6 Transmitter |
| Sonex Health, INC. | $15.73 | 2023 | Sx-One Microknife |
| Shire North American Group INC | $15.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Houng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.